<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28991189</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>10</Issue><PubDate><Year>2017</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Translational Implication of Galectin-9 in the Pathogenesis and Treatment of Viral Infection.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2108</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms18102108</ELocationID><Abstract><AbstractText>The interaction between galectin-9 and its receptor, Tim-3, triggers a series of signaling events that regulate immune responses. The expression of galectin-9 has been shown to be increased in a variety of target cells of many different viruses, such as hepatitis C virus (HCV), hepatitis B virus (HBV), herpes simplex virus (HSV), influenza virus, dengue virus (DENV), and human immunodeficiency virus (HIV). This enhanced expression of galectin-9 following viral infection promotes significant changes in the behaviors of the virus-infected cells, and the resulting events tightly correlate with the immunopathogenesis of the viral disease. Because the human immune response to different viral infections can vary, and the lack of appropriate treatment can have potentially fatal consequences, understanding the implications of galectin-9 is crucial for developing better methods for monitoring and treating viral infections. This review seeks to address how we can apply the current understanding of galectin-9 function to better understand the pathogenesis of viral infection and better treat viral diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Jenn-Haung</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, Tao-Yuan 33305, Taiwan. laiandho@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Medical Science, National Defense Medical Center, Taipei 11490, Taiwan. laiandho@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Shue-Fen</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, Tao-Yuan 33305, Taiwan. lsf00076@adm.cgmh.org.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Mei-Yi</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, Tao-Yuan 33305, Taiwan. meiyiwang800106@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Ling-Jun</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Institute of Cellular and System Medicine, National Health Research Institute, Zhunan 35053, Taiwan. lingjunho@nhri.org.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037161">Galectins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C105032">LGALS9 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D037161" MajorTopicYN="N">Galectins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016174" MajorTopicYN="N">Hepacivirus</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018139" MajorTopicYN="N">Simplexvirus</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057170" MajorTopicYN="N">Translational Research, Biomedical</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="N">Virus Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">galectin-9</Keyword><Keyword MajorTopicYN="N">pathogenesis</Keyword><Keyword MajorTopicYN="N">translational medicine</Keyword><Keyword MajorTopicYN="N">treatment</Keyword><Keyword MajorTopicYN="N">viral infection</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28991189</ArticleId><ArticleId IdType="pmc">PMC5666790</ArticleId><ArticleId IdType="doi">10.3390/ijms18102108</ArticleId><ArticleId IdType="pii">ijms18102108</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vasta G.R. Galectins as pattern recognition receptors: Structure, function, and evolution. Adv. Exp. Med. Biol. 2012;946:21&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3429938</ArticleId><ArticleId IdType="pubmed">21948360</ArticleId></ArticleIdList></Reference><Reference><Citation>Nio-Kobayashi J. Tissue- and cell-specific localization of galectins, &#x3b2;-galactose-binding animal lectins, and their potential functions in health and disease. Anat. Sci. Int. 2017;92:25&#x2013;36. doi: 10.1007/s12565-016-0366-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12565-016-0366-6</ArticleId><ArticleId IdType="pubmed">27590897</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada J., Kanwar Y.S. Identification and characterization of galectin-9, a novel &#x3b2;-galactoside-binding mammalian lectin. J. Biol. Chem. 1997;272:6078&#x2013;6086. doi: 10.1074/jbc.272.9.6078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.272.9.6078</ArticleId><ArticleId IdType="pubmed">9038233</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirashima M. Ecalectin/galectin-9, a novel eosinophil chemoattractant: Its function and production. Int. Arch. Allergy Immunol. 2000;122(Suppl. 1):6&#x2013;9. doi: 10.1159/000053623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000053623</ArticleId><ArticleId IdType="pubmed">10867499</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirashima M., Kashio Y., Nishi N., Yamauchi A., Imaizumi T.A., Kageshita T., Saita N., Nakamura T. Galectin-9 in physiological and pathological conditions. Glycoconj. J. 2004;19:593&#x2013;600. doi: 10.1023/B:GLYC.0000014090.63206.2f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:GLYC.0000014090.63206.2f</ArticleId><ArticleId IdType="pubmed">14758084</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovich G.A., Croci D.O. Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer. Immunity. 2012;36:322&#x2013;335. doi: 10.1016/j.immuni.2012.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.03.004</ArticleId><ArticleId IdType="pubmed">22444630</ArticleId></ArticleIdList></Reference><Reference><Citation>Harwood N.M., Golden-Mason L., Cheng L., Rosen H.R., Mengshol J.A. HCV-infected cells and differentiation increase monocyte immunoregulatory galectin-9 production. J. Leukoc. Biol. 2016;99:495&#x2013;503. doi: 10.1189/jlb.5A1214-582R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.5A1214-582R</ArticleId><ArticleId IdType="pmc">PMC6608045</ArticleId><ArticleId IdType="pubmed">26475932</ArticleId></ArticleIdList></Reference><Reference><Citation>Mengshol J.A., Golden-Mason L., Arikawa T., Smith M., Niki T., McWilliams R., Randall J.A., McMahan R., Zimmerman M.A., Rangachari M., et al. A crucial role for kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis c infection. PLoS ONE. 2010;5:e9504. doi: 10.1371/annotation/d15b793c-85c7-4529-bc80-aabcb088a8cf.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/annotation/d15b793c-85c7-4529-bc80-aabcb088a8cf</ArticleId><ArticleId IdType="pmc">PMC2831996</ArticleId><ArticleId IdType="pubmed">20209097</ArticleId></ArticleIdList></Reference><Reference><Citation>Chabot S., Kashio Y., Seki M., Shirato Y., Nakamura K., Nishi N., Nakamura T., Matsumoto R., Hirashima M. Regulation of galectin-9 expression and release in jurkat T cell line cells. Glycobiology. 2002;12:111&#x2013;118. doi: 10.1093/glycob/12.2.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/glycob/12.2.111</ArticleId><ArticleId IdType="pubmed">11886844</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai S.Y., Nakagawa R., Itoh A., Murakami H., Kashio Y., Abe H., Katoh S., Kontani K., Kihara M., Zhang S.L., et al. Galectin-9 induces maturation of human monocyte-derived dendritic cells. J. Immunol. 2005;175:2974&#x2013;2981. doi: 10.4049/jimmunol.175.5.2974.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.175.5.2974</ArticleId><ArticleId IdType="pubmed">16116184</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahan R.H., Golden-Mason L., Nishimura M.I., McMahon B.J., Kemper M., Allen T.M., Gretch D.R., Rosen H.R. Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J. Clin. Invest. 2010;120:4546&#x2013;4557. doi: 10.1172/JCI43127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI43127</ArticleId><ArticleId IdType="pmc">PMC2994339</ArticleId><ArticleId IdType="pubmed">21084749</ArticleId></ArticleIdList></Reference><Reference><Citation>Golden-Mason L., McMahan R.H., Strong M., Reisdorph R., Mahaffey S., Palmer B.E., Cheng L., Kulesza C., Hirashima M., Niki T., et al. Galectin-9 functionally impairs natural killer cells in humans and mice. J. Virol. 2013;87:4835&#x2013;4845. doi: 10.1128/JVI.01085-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01085-12</ArticleId><ArticleId IdType="pmc">PMC3624298</ArticleId><ArticleId IdType="pubmed">23408620</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Wu K., Tao K., Chen L., Zheng Q., Lu X., Liu J., Shi L., Liu C., Wang G., et al. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis b virus-associated hepatocellular carcinoma. Hepatology. 2012;56:1342&#x2013;1351. doi: 10.1002/hep.25777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.25777</ArticleId><ArticleId IdType="pubmed">22505239</ArticleId></ArticleIdList></Reference><Reference><Citation>Sehrawat S., Reddy P.B., Rajasagi N., Suryawanshi A., Hirashima M., Rouse B.T. Galectin-9/Tim-3 interaction regulates virus-specific primary and memory CD8 T cell response. PLoS Pathog. 2010;6:e1000882. doi: 10.1371/journal.ppat.1000882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000882</ArticleId><ArticleId IdType="pmc">PMC2865527</ArticleId><ArticleId IdType="pubmed">20463811</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy P.B., Sehrawat S., Suryawanshi A., Rajasagi N.K., Mulik S., Hirashima M., Rouse B.T. Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. J. Immunol. 2011;187:5745&#x2013;5755. doi: 10.4049/jimmunol.1102105.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1102105</ArticleId><ArticleId IdType="pmc">PMC3221893</ArticleId><ArticleId IdType="pubmed">22021615</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S., Sundararajan A., Suryawanshi A., Kumar N., Veiga-Parga T., Kuchroo V.K., Thomas P.G., Sangster M.Y., Rouse B.T. T cell immunoglobulin and mucin protein-3 (Tim-3)/galectin-9 interaction regulates influenza a virus-specific humoral and CD8 T-cell responses. Proc. Natl. Acad. Sci. USA. 2011;108:19001&#x2013;19006. doi: 10.1073/pnas.1107087108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1107087108</ArticleId><ArticleId IdType="pmc">PMC3223445</ArticleId><ArticleId IdType="pubmed">22052881</ArticleId></ArticleIdList></Reference><Reference><Citation>Klibi J., Niki T., Riedel A., Pioche-Durieu C., Souquere S., Rubinstein E., Le Moulec S., Guigay J., Hirashima M., Guemira F., et al. Blood diffusion and TH1-suppressive effects of galectin-9-containing exosomes released by epstein-barr virus-infected nasopharyngeal carcinoma cells. Blood. 2009;113:1957&#x2013;1966. doi: 10.1182/blood-2008-02-142596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2008-02-142596</ArticleId><ArticleId IdType="pubmed">19005181</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K.T., Liu Y.H., Chen Y.H., Lin C.Y., Huang C.H., Yen M.C., Kuo P.L. Serum galectin-9 and galectin-3-binding protein in acute dengue virus infection. Int. J. Mol. Sci. 2016;17:832. doi: 10.3390/ijms17060832.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms17060832</ArticleId><ArticleId IdType="pmc">PMC4926366</ArticleId><ArticleId IdType="pubmed">27240351</ArticleId></ArticleIdList></Reference><Reference><Citation>Dapat I.C., Pascapurnama D.N., Iwasaki H., Labayo H.K., Chagan-Yasutan H., Egawa S., Hattori T. Secretion of galectin-9 as a damp during dengue virus infection in thp-1 cells. Int. J. Mol. Sci. 2017;18:1644. doi: 10.3390/ijms18081644.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18081644</ArticleId><ArticleId IdType="pmc">PMC5578034</ArticleId><ArticleId IdType="pubmed">28788062</ArticleId></ArticleIdList></Reference><Reference><Citation>Jost S., Moreno-Nieves U.Y., Garcia-Beltran W.F., Rands K., Reardon J., Toth I., Piechocka-Trocha A., Altfeld M., Addo M.M. Dysregulated Tim-3 expression on natural killer cells is associated with increased galectin-9 levels in HIV-1 infection. Retrovirology. 2013;10:74. doi: 10.1186/1742-4690-10-74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4690-10-74</ArticleId><ArticleId IdType="pmc">PMC3750478</ArticleId><ArticleId IdType="pubmed">23866914</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J.Y., Zou Z.S., Huang A., Zhang Z., Fu J.L., Xu X.S., Chen L.M., Li B.S., Wang F.S. Hyper-activated pro-inflammatory CD16+ monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B. PLoS ONE. 2011;6:e17484. doi: 10.1371/journal.pone.0017484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0017484</ArticleId><ArticleId IdType="pmc">PMC3046987</ArticleId><ArticleId IdType="pubmed">21390263</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu C., Anderson A.C., Schubart A., Xiong H., Imitola J., Khoury S.J., Zheng X.X., Strom T.B., Kuchroo V.K. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 2005;6:1245&#x2013;1252. doi: 10.1038/ni1271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1271</ArticleId><ArticleId IdType="pubmed">16286920</ArticleId></ArticleIdList></Reference><Reference><Citation>Sada-Ovalle I., Ocana-Guzman R., Perez-Patrigeon S., Chavez-Galan L., Sierra-Madero J., Torre-Bouscoulet L., Addo M.M. Tim-3 blocking rescue macrophage and T cell function against mycobacterium tuberculosis infection in HIV+ patients. J. Int. AIDS Soc. 2015;18:20078. doi: 10.7448/IAS.18.1.20078.</Citation><ArticleIdList><ArticleId IdType="doi">10.7448/IAS.18.1.20078</ArticleId><ArticleId IdType="pmc">PMC4612469</ArticleId><ArticleId IdType="pubmed">26486200</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncalves Silva I., Ruegg L., Gibbs B.F., Bardelli M., Fruehwirth A., Varani L., Berger S.M., Fasler-Kan E., Sumbayev V.V. The immune receptor Tim-3 acts as a trafficker in a Tim-3/galectin-9 autocrine loop in human myeloid leukemia cells. Oncoimmunology. 2016;5:e1195535. doi: 10.1080/2162402X.2016.1195535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/2162402X.2016.1195535</ArticleId><ArticleId IdType="pmc">PMC5006895</ArticleId><ArticleId IdType="pubmed">27622049</ArticleId></ArticleIdList></Reference><Reference><Citation>Su E.W., Bi S., Kane L.P. Galectin-9 regulates T helper cell function independently of Tim-3. Glycobiology. 2011;21:1258&#x2013;1265. doi: 10.1093/glycob/cwq214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/glycob/cwq214</ArticleId><ArticleId IdType="pmc">PMC3167474</ArticleId><ArticleId IdType="pubmed">21187321</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitner J., Rieger A., Pickl W.F., Zlabinger G., Grabmeier-Pfistershammer K., Steinberger P. Tim-3 does not act as a receptor for galectin-9. PLoS Pathog. 2013;9:e1003253. doi: 10.1371/journal.ppat.1003253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003253</ArticleId><ArticleId IdType="pmc">PMC3605152</ArticleId><ArticleId IdType="pubmed">23555261</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton K.L., Haaland M.S., Douglas-Vail M.B., Mujib S., Chew G.M., Ndhlovu L.C., Ostrowski M.A. T cell ig and mucin domain-containing protein 3 is recruited to the immune synapse, disrupts stable synapse formation, and associates with receptor phosphatases. J. Immunol. 2014;192:782&#x2013;791. doi: 10.4049/jimmunol.1302663.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1302663</ArticleId><ArticleId IdType="pmc">PMC4214929</ArticleId><ArticleId IdType="pubmed">24337741</ArticleId></ArticleIdList></Reference><Reference><Citation>Katoh S., Ishii N., Nobumoto A., Takeshita K., Dai S.Y., Shinonaga R., Niki T., Nishi N., Tominaga A., Yamauchi A., et al. Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma. Am. J. Respir. Crit. Care Med. 2007;176:27&#x2013;35. doi: 10.1164/rccm.200608-1243OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200608-1243OC</ArticleId><ArticleId IdType="pubmed">17446336</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi S., Hong P.W., Lee B., Baum L.G. Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry. Proc. Natl. Acad. Sci. USA. 2011;108:10650&#x2013;10655. doi: 10.1073/pnas.1017954108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1017954108</ArticleId><ArticleId IdType="pmc">PMC3127870</ArticleId><ArticleId IdType="pubmed">21670307</ArticleId></ArticleIdList></Reference><Reference><Citation>Moritoki M., Kadowaki T., Niki T., Nakano D., Soma G., Mori H., Kobara H., Masaki T., Kohno M., Hirashima M. Galectin-9 ameliorates clinical severity of MRL/LPR lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3. PLoS ONE. 2013;8:e60807. doi: 10.1371/journal.pone.0060807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0060807</ArticleId><ArticleId IdType="pmc">PMC3621869</ArticleId><ArticleId IdType="pubmed">23585851</ArticleId></ArticleIdList></Reference><Reference><Citation>Lhuillier C., Barjon C., Niki T., Gelin A., Praz F., Morales O., Souquere S., Hirashima M., Wei M., Dellis O., et al. Impact of exogenous galectin-9 on human T cells: Contribution of the T cell receptor complex to antigen-independent activation but not to apoptosis induction. J. Biol. Chem. 2015;290:16797&#x2013;16811. doi: 10.1074/jbc.M115.661272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.661272</ArticleId><ArticleId IdType="pmc">PMC4505427</ArticleId><ArticleId IdType="pubmed">25947381</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao E., Zang X., Ramagopal U.A., Mukhopadhaya A., Fedorov A., Fedorov E., Zencheck W.D., Lary J.W., Cole J.L., Deng H., et al. T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface. Immunity. 2007;26:311&#x2013;321. doi: 10.1016/j.immuni.2007.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2007.01.016</ArticleId><ArticleId IdType="pubmed">17363302</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama M., Akiba H., Takeda K., Kojima Y., Hashiguchi M., Azuma M., Yagita H., Okumura K. Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood. 2009;113:3821&#x2013;3830. doi: 10.1182/blood-2008-10-185884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2008-10-185884</ArticleId><ArticleId IdType="pubmed">19224762</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y.H., Zhu C., Kondo Y., Anderson A.C., Gandhi A., Russell A., Dougan S.K., Petersen B.S., Melum E., Pertel T., et al. Ceacam1 regulates Tim-3-mediated tolerance and exhaustion. Nature. 2015;517:386&#x2013;390. doi: 10.1038/nature13848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13848</ArticleId><ArticleId IdType="pmc">PMC4297519</ArticleId><ArticleId IdType="pubmed">25363763</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiba S., Baghdadi M., Akiba H., Yoshiyama H., Kinoshita I., Dosaka-Akita H., Fujioka Y., Ohba Y., Gorman J.V., Colgan J.D., et al. Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat. Immunol. 2012;13:832&#x2013;842. doi: 10.1038/ni.2376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2376</ArticleId><ArticleId IdType="pmc">PMC3622453</ArticleId><ArticleId IdType="pubmed">22842346</ArticleId></ArticleIdList></Reference><Reference><Citation>Jemielity S., Wang J.J., Chan Y.K., Ahmed A.A., Li W., Monahan S., Bu X., Farzan M., Freeman G.J., Umetsu D.T., et al. Tim-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine. PLoS Pathog. 2013;9:e1003232. doi: 10.1371/journal.ppat.1003232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003232</ArticleId><ArticleId IdType="pmc">PMC3610696</ArticleId><ArticleId IdType="pubmed">23555248</ArticleId></ArticleIdList></Reference><Reference><Citation>Sui L., Zhang W., Chen Y., Zheng Y., Wan T., Zhang W., Yang Y., Fang G., Mao J., Cao X. Human membrane protein Tim-3 facilitates hepatitis a virus entry into target cells. Int. J. Mol. Med. 2006;17:1093&#x2013;1099. doi: 10.3892/ijmm.17.6.1093.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.17.6.1093</ArticleId><ArticleId IdType="pubmed">16685421</ArticleId></ArticleIdList></Reference><Reference><Citation>Meertens L., Carnec X., Lecoin M.P., Ramdasi R., Guivel-Benhassine F., Lew E., Lemke G., Schwartz O., Amara A. The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell. Host Microbe. 2012;12:544&#x2013;557. doi: 10.1016/j.chom.2012.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2012.08.009</ArticleId><ArticleId IdType="pmc">PMC3572209</ArticleId><ArticleId IdType="pubmed">23084921</ArticleId></ArticleIdList></Reference><Reference><Citation>Dam T.K., Brewer C.F. Maintenance of cell surface glycan density by lectin-glycan interactions: A homeostatic and innate immune regulatory mechanism. Glycobiology. 2010;20:1061&#x2013;1064. doi: 10.1093/glycob/cwq084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/glycob/cwq084</ArticleId><ArticleId IdType="pubmed">20548106</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovich G.A., Toscano M.A. Turning &#x2018;sweet&#x2019; on immunity: Galectin-glycan interactions in immune tolerance and inflammation. Nat. Rev. Immunol. 2009;9:338&#x2013;352. doi: 10.1038/nri2536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2536</ArticleId><ArticleId IdType="pubmed">19365409</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson A.C., Anderson D.E., Bregoli L., Hastings W.D., Kassam N., Lei C., Chandwaskar R., Karman J., Su E.W., Hirashima M., et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science. 2007;318:1141&#x2013;1143. doi: 10.1126/science.1148536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1148536</ArticleId><ArticleId IdType="pubmed">18006747</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson A.C., Anderson D.E. Tim-3 in autoimmunity. Curr. Opin. Immunol. 2006;18:665&#x2013;669. doi: 10.1016/j.coi.2006.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2006.09.009</ArticleId><ArticleId IdType="pubmed">17011764</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita K., Iwama H., Oura K., Tadokoro T., Samukawa E., Sakamoto T., Nomura T., Tani J., Yoneyama H., Morishita A., et al. Cancer therapy due to apoptosis: Galectin-9. Int. J. Mol. Sci. 2017;18:74. doi: 10.3390/ijms18010074.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18010074</ArticleId><ArticleId IdType="pmc">PMC5297709</ArticleId><ArticleId IdType="pubmed">28045432</ArticleId></ArticleIdList></Reference><Reference><Citation>Seki M., Oomizu S., Sakata K.M., Sakata A., Arikawa T., Watanabe K., Ito K., Takeshita K., Niki T., Saita N., et al. Galectin-9 suppresses the generation of TH17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin. Immunol. 2008;127:78&#x2013;88. doi: 10.1016/j.clim.2008.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2008.01.006</ArticleId><ArticleId IdType="pubmed">18282810</ArticleId></ArticleIdList></Reference><Reference><Citation>Leskela S., Serrano A., de la Fuente H., Rodriguez-Munoz A., Ramos-Levi A., Sampedro-Nunez M., Sanchez-Madrid F., Gonzalez-Amaro R., Marazuela M. Graves&#x2019; disease is associated with a defective expression of the immune regulatory molecule galectin-9 in antigen-presenting dendritic cells. PLoS ONE. 2015;10:e0123938. doi: 10.1371/journal.pone.0123938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0123938</ArticleId><ArticleId IdType="pmc">PMC4399981</ArticleId><ArticleId IdType="pubmed">25880730</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Oh J.M., Hwang J.W., Ahn J.K., Bae E.K., Won J., Koh E.M., Cha H.S. Expression of human Tim-3 and its correlation with disease activity in rheumatoid arthritis. Scand. J. Rheumatol. 2011;40:334&#x2013;340. doi: 10.3109/03009742.2010.547871.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/03009742.2010.547871</ArticleId><ArticleId IdType="pubmed">21446887</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung S.H., Hwang J.H., Kim S.E., Kim Y.K., Park H.C., Lee H.T. Human galectin-9 on the porcine cells affects the cytotoxic activity of M1-differentiated THP-1 cells through inducing a shift in M2-differentiated THP-1 cells. Xenotransplantation. 2017 doi: 10.1111/xen.12305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/xen.12305</ArticleId><ArticleId IdType="pubmed">28432704</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Fueyo A., Tian J., Picarella D., Domenig C., Zheng X.X., Sabatos C.A., Manlongat N., Bender O., Kamradt T., Kuchroo V.K., et al. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat. Immunol. 2003;4:1093&#x2013;1101. doi: 10.1038/ni987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni987</ArticleId><ArticleId IdType="pubmed">14556005</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.L., Jones M.B., Ryan S.O., Cobb B.A. The regulatory power of glycans and their binding partners in immunity. Trends Immunol. 2013;34:290&#x2013;298. doi: 10.1016/j.it.2013.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2013.01.006</ArticleId><ArticleId IdType="pmc">PMC3674136</ArticleId><ArticleId IdType="pubmed">23485517</ArticleId></ArticleIdList></Reference><Reference><Citation>Burman J., Svenningsson A. Cerebrospinal fluid concentration of galectin-9 is increased in secondary progressive multiple sclerosis. J. Neuroimmunol. 2016;292:40&#x2013;44. doi: 10.1016/j.jneuroim.2016.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2016.01.008</ArticleId><ArticleId IdType="pubmed">26943957</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleason M.K., Lenvik T.R., McCullar V., Felices M., O&#x2019;Brien M.S., Cooley S.A., Verneris M.R., Cichocki F., Holman C.J., Panoskaltsis-Mortari A., et al. Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9. Blood. 2012;119:3064&#x2013;3072. doi: 10.1182/blood-2011-06-360321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-06-360321</ArticleId><ArticleId IdType="pmc">PMC3321868</ArticleId><ArticleId IdType="pubmed">22323453</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks A.K., Lawson M.A., Rytych J.L., Yu K.C., Janda T.M., Steelman A.J., McCusker R.H. Immunomodulatory factors galectin-9 and interferon-gamma synergize to induce expression of rate-limiting enzymes of the kynurenine pathway in the mouse hippocampus. Front. Immunol. 2016;7:422. doi: 10.3389/fimmu.2016.00422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00422</ArticleId><ArticleId IdType="pmc">PMC5065983</ArticleId><ArticleId IdType="pubmed">27799931</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagae M., Nishi N., Murata T., Usui T., Nakamura T., Wakatsuki S., Kato R. Crystal structure of the galectin-9 n-terminal carbohydrate recognition domain from mus musculus reveals the basic mechanism of carbohydrate recognition. J. Biol. Chem. 2006;281:35884&#x2013;35893. doi: 10.1074/jbc.M606648200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M606648200</ArticleId><ArticleId IdType="pubmed">16990264</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida H., Teraoka M., Nishi N., Nakakita S., Nakamura T., Hirashima M., Kamitori S. X-ray structures of human galectin-9 C-terminal domain in complexes with a biantennary oligosaccharide and sialyllactose. J. Biol. Chem. 2010;285:36969&#x2013;36976. doi: 10.1074/jbc.M110.163402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.163402</ArticleId><ArticleId IdType="pmc">PMC2978625</ArticleId><ArticleId IdType="pubmed">20861009</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Feng J., Geng S., Geng S., Wei H., Chen G., Li X., Wang L., Wang R., Peng H., et al. The N- and C-terminal carbohydrate recognition domains of galectin-9 contribute differently to its multiple functions in innate immunity and adaptive immunity. Mol. Immunol. 2011;48:670&#x2013;677. doi: 10.1016/j.molimm.2010.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2010.11.011</ArticleId><ArticleId IdType="pubmed">21146220</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen D.G., Walker C.M. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature. 2005;436:946&#x2013;952. doi: 10.1038/nature04079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04079</ArticleId><ArticleId IdType="pubmed">16107834</ArticleId></ArticleIdList></Reference><Reference><Citation>Kared H., Fabre T., Bedard N., Bruneau J., Shoukry N.H. Galectin-9 and IL-21 mediate cross-regulation between TH17 and Treg cells during acute hepatitis C. PLoS Pathog. 2013;9:e1003422. doi: 10.1371/journal.ppat.1003422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003422</ArticleId><ArticleId IdType="pmc">PMC3688567</ArticleId><ArticleId IdType="pubmed">23818845</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji X.J., Ma C.J., Wang J.M., Wu X.Y., Niki T., Hirashima M., Moorman J.P., Yao Z.Q. HCV-infected hepatocytes drive CD4+ CD25+ foxp3+ regulatory T-cell development through the Tim-3/Gal-9 pathway. Eur. J. Immunol. 2013;43:458&#x2013;467. doi: 10.1002/eji.201242768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201242768</ArticleId><ArticleId IdType="pmc">PMC3757554</ArticleId><ArticleId IdType="pubmed">23161469</ArticleId></ArticleIdList></Reference><Reference><Citation>Nebbia G., Peppa D., Schurich A., Khanna P., Singh H.D., Cheng Y., Rosenberg W., Dusheiko G., Gilson R., ChinAleong J., et al. Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS ONE. 2012;7:e47648. doi: 10.1371/journal.pone.0047648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0047648</ArticleId><ArticleId IdType="pmc">PMC3480425</ArticleId><ArticleId IdType="pubmed">23112829</ArticleId></ArticleIdList></Reference><Reference><Citation>McSharry B.P., Forbes S.K., Cao J.Z., Avdic S., Machala E.A., Gottlieb D.J., Abendroth A., Slobedman B. Human cytomegalovirus upregulates expression of the lectin galectin 9 via induction of &#x3b2; interferon. J. Virol. 2014;88:10990&#x2013;10994. doi: 10.1128/JVI.01259-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01259-14</ArticleId><ArticleId IdType="pmc">PMC4178876</ArticleId><ArticleId IdType="pubmed">25008927</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Mohsen M., Chavez L., Tandon R., Chew G.M., Deng X., Danesh A., Keating S., Lanteri M., Samuels M.L., Hoh R., et al. Human galectin-9 is a potent mediator of HIV transcription and reactivation. PLoS Pathog. 2016;12:e1005677. doi: 10.1371/journal.ppat.1005677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005677</ArticleId><ArticleId IdType="pmc">PMC4890776</ArticleId><ArticleId IdType="pubmed">27253379</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuo Y., Zhang Y.F., Wu H.J., Qin L., Wang Y.P., Liu A.M., Wang X.H. Interaction between galectin-9/Tim-3 pathway and follicular helper CD4+ T cells contributes to viral persistence in chronic hepatitis C. Biomed. Pharmacother. 2017;94:386&#x2013;393. doi: 10.1016/j.biopha.2017.07.134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2017.07.134</ArticleId><ArticleId IdType="pubmed">28772217</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu Y.L., Wang M.Y., Ho L.J., Huang C.Y., Lai J.H. Up-regulation of galectin-9 induces cell migration in human dendritic cells infected with dengue virus. J. Cell. Mol. Med. 2015;19:1065&#x2013;1076. doi: 10.1111/jcmm.12500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.12500</ArticleId><ArticleId IdType="pmc">PMC4420608</ArticleId><ArticleId IdType="pubmed">25754930</ArticleId></ArticleIdList></Reference><Reference><Citation>Tandon R., Chew G.M., Byron M.M., Borrow P., Niki T., Hirashima M., Barbour J.D., Norris P.J., Lanteri M.C., Martin J.N., et al. Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers. AIDS Res. Hum. Retroviruses. 2014;30:654&#x2013;664. doi: 10.1089/aid.2014.0004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/aid.2014.0004</ArticleId><ArticleId IdType="pmc">PMC4077009</ArticleId><ArticleId IdType="pubmed">24786365</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton K.L., Douglas-Vail M.B., Nur-ur Rahman A.K., Medcalf K.E., Xie I.Y., Chew G.M., Tandon R., Lanteri M.C., Norris P.J., Deeks S.G., et al. Soluble T cell immunoglobulin mucin domain 3 is shed from CD8+ T cells by the sheddase adam10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progression. J. Virol. 2015;89:3723&#x2013;3736. doi: 10.1128/JVI.00006-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00006-15</ArticleId><ArticleId IdType="pmc">PMC4403393</ArticleId><ArticleId IdType="pubmed">25609823</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz J.A., Clayton K.L., Mujib S., Zhang H., Rahman A.K., Liu J., Yue F.Y., Benko E., Kovacs C., Ostrowski M.A. Tim-3 is a marker of plasmacytoid dendritic cell dysfunction during HIV infection and is associated with the recruitment of IRF7 and p85 into lysosomes and with the submembrane displacement of TLR9. J. Immunol. 2017;198:3181&#x2013;3194. doi: 10.4049/jimmunol.1601298.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1601298</ArticleId><ArticleId IdType="pubmed">28264968</ArticleId></ArticleIdList></Reference><Reference><Citation>Chagan-Yasutan H., Ndhlovu L.C., Lacuesta T.L., Kubo T., Leano P.S., Niki T., Oguma S., Morita K., Chew G.M., Barbour J.D., et al. Galectin-9 plasma levels reflect adverse hematological and immunological features in acute dengue virus infection. J. Clin. Virol. 2013;58:635&#x2013;640. doi: 10.1016/j.jcv.2013.10.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2013.10.022</ArticleId><ArticleId IdType="pmc">PMC3880569</ArticleId><ArticleId IdType="pubmed">24239423</ArticleId></ArticleIdList></Reference><Reference><Citation>Golden-Mason L., Rosen H.R. Galectin-9: Diverse roles in hepatic immune homeostasis and inflammation. Hepatology. 2017;66:271&#x2013;279. doi: 10.1002/hep.29106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.29106</ArticleId><ArticleId IdType="pmc">PMC5521806</ArticleId><ArticleId IdType="pubmed">28195343</ArticleId></ArticleIdList></Reference><Reference><Citation>Merani S., Chen W., Elahi S. The bitter side of sweet: The role of galectin-9 in immunopathogenesis of viral infections. Rev. Med. Virol. 2015;25:175&#x2013;186. doi: 10.1002/rmv.1832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1832</ArticleId><ArticleId IdType="pubmed">25760439</ArticleId></ArticleIdList></Reference><Reference><Citation>PB J.R., Schreiber T.H., Rajasagi N.K., Suryawanshi A., Mulik S., Veiga-Parga T., Niki T., Hirashima M., Podack E.R., Rouse B.T. TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions. J. Virol. 2012;86:10606&#x2013;10620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3457251</ArticleId><ArticleId IdType="pubmed">22811539</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim J.A., Park S., Lee E.S., Niki T., Hirashima M., Sohn S. Galectin-9 ameliorates herpes simplex virus-induced inflammation through apoptosis. Immunobiology. 2012;217:657&#x2013;666. doi: 10.1016/j.imbio.2011.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2011.11.002</ArticleId><ArticleId IdType="pubmed">22204815</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu X., McCoy K.S., Xu J., Hu W., Chen H., Jiang K., Han F., Chen P., Wang Y. Galectin-9 ameliorates respiratory syncytial virus-induced pulmonary immunopathology through regulating the balance between TH17 and regulatory T cells. Virus Res. 2015;195:162&#x2013;171. doi: 10.1016/j.virusres.2014.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.10.011</ArticleId><ArticleId IdType="pubmed">25451068</ArticleId></ArticleIdList></Reference><Reference><Citation>Elahi S., Niki T., Hirashima M., Horton H. Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection. Blood. 2012;119:4192&#x2013;4204. doi: 10.1182/blood-2011-11-389585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-11-389585</ArticleId><ArticleId IdType="pmc">PMC3359739</ArticleId><ArticleId IdType="pubmed">22438246</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai J.H., Lin Y.L., Hsieh S.L. Pharmacological intervention for dengue virus infection. Biochem. Pharmacol. 2017;129:14&#x2013;25. doi: 10.1016/j.bcp.2017.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2017.01.005</ArticleId><ArticleId IdType="pubmed">28104437</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangachari M., Zhu C., Sakuishi K., Xiao S., Karman J., Chen A., Angin M., Wakeham A., Greenfield E.A., Sobel R.A., et al. Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion. Nat. Med. 2012;18:1394&#x2013;1400. doi: 10.1038/nm.2871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2871</ArticleId><ArticleId IdType="pmc">PMC3491118</ArticleId><ArticleId IdType="pubmed">22863785</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>